Functional genomics and proteomics – the role of nuclear medicine

作者: Uwe Haberkorn , Annette Altmann , Michael Eisenhut

DOI: 10.1007/S00259-001-0682-4

关键词:

摘要: Now that the sequencing of human genome has been completed, basic challenges are finding genes, locating their coding regions and predicting functions. This will result in a new understanding biology as well design molecular structures potential novel diagnostic or drug discovery targets. The assessment gene function may be performed using tools program. These represent high-throughput methods used to evaluate changes expression many all genes an organism at same time order investigate genetic pathways for normal development disease. lead shift scientific paradigm: In pre-proteomics era, functional assignments were derived from hypothesis-driven experiments designed understand specific cellular processes. describe proteins on proteome-wide scale, thereby creating way doing cell research which results determination three-dimensional protein description networks. descriptions then hypotheses traditional physiological, biochemical pharmacological sense. evaluation genetically manipulated animals newly biomolecules require thorough physiology, biochemistry pharmacology experimental approaches involve technologies, including vivo imaging with single-photon emission tomography positron tomography. Nuclear medicine procedures applied regulation established tracers reporter such enzymes, receptors, antigens transporters. Pharmacogenomics identify surrogate markers therapy monitoring imaging. Also, distribution studies therapeutic needed, least during preclinical stages development. Finally, developed by bioengineering isotope-based diagnosis treatment

参考文章(58)
Benno Schwikowski, Peter Uetz, Stanley Fields, A NETWORK OF PROTEIN?PROTEIN INTERACTIONS IN YEAST Nature Biotechnology. ,vol. 18, pp. 1257- 1261 ,(2000) , 10.1038/82360
Stephen B. Liggett, Pharmacogenetic applications of the Human Genome project. Nature Medicine. ,vol. 7, pp. 281- 283 ,(2001) , 10.1038/85411
Norbert Avril, Ronald Finn, Bradley Beattie, Steven M. Larson, Farhad Daghighian, Jamal Zweit, Michelle Safer, Gene DiResta, Revathi Joshi, Takamitsu Oku, Toshio Sasajima, Jason Koutcher, Ronald Blasberg, Finn Augensen, John Humm, Juri G. Tjuvajev, Tadashi Miyagawa, Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Research. ,vol. 58, pp. 4333- 4341 ,(1998)
Roland Hustinx, Chyng-Yann Shiue, Abass Alavi, Douglas McDonald, Grace G. Shiue, Hongming Zhuang, Mike Lanuti, Eric Lambright, Joel S. Karp, Stephen L. Eck, Imaging in vivo herpes simplex virus thymidine kinase gene transfer to tumour-bearing rodents using positron emission tomography and [18F]FHPG European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 28, pp. 5- 12 ,(2001) , 10.1007/S002590000396
Stanley Fields, Proteomics in Genomeland Science. ,vol. 291, pp. 1221- 1224 ,(2001) , 10.1126/SCIENCE.291.5507.1221
Stephen K Burley, Steven C Almo, Jeffrey B Bonanno, Malcolm Capel, Mark R Chance, Terry Gaasterland, Dawei Lin, Andrej Šali, F. William Studier, Subramanyam Swaminathan, Structural genomics: beyond the human genome project. Nature Genetics. ,vol. 23, pp. 151- 157 ,(1999) , 10.1038/13783
K D Tew, L Barone, D Rosser, A Monks, G Akerman, J B Wheatley, D E Schmidt, J A Montali, Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program. Molecular Pharmacology. ,vol. 50, pp. 149- 159 ,(1996)
John Schimenti, Maja Bucan, Functional Genomics in the Mouse: Phenotype-Based Mutagenesis Screens Genome Research. ,vol. 8, pp. 698- 710 ,(1998) , 10.1101/GR.8.7.698
Uwe Haberkorn, Annette Altmann, Huse Kamencic, Iris Morr, Ulrike Traut, Marcus Henze, Shiming Jiang, Jürgen Metz, Ralf Kinscherf, Glucose transport and apoptosis after gene therapy with HSV thymidine kinase. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 28, pp. 1690- 1696 ,(2001) , 10.1007/S002590100644